News Archives - Page 88 of 1183 - BioHealth Innovation

News

May 21, 2023

From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of AMPEL BioSolutions, Joins BioTalk

Can you envision a world where precision medicine transforms healthcare as we know it? Tune in to this exciting episode…

Andy

Love0

News

May 18, 2023

Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

RICHMOND, VA – May 18, 2023 – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC),…

Andy

Love0

News

May 18, 2023

PQE Group US Earns 2023 Great Place To Work Certification™

PQE Group receives certification in the U.S. as a work environment where “you trust the people you work for, take…

Andy

Love0

News

May 18, 2023

Baltimore’s Flavocure Biotech Announces FDA Clearance of IND Application for Caflanone (FBL-03G), for Clinical Trials in Pancreatic Cancer Patients.

Baltimore, Maryland--(Newsfile Corp. - May 17, 2023) - Flavocure Biotech, Inc. ("Flavocure"), today announced that it has received clearance of…

Andy

Love0

News

May 18, 2023

REGENXBIO Announces NAV® Technology Platform Will Support Bespoke Gene Therapy Consortium’s First Rare Disease Clinical Portfolio

ROCKVILLE, Md., May 16, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that preclinical research in Mucopolysaccharidosis type IVA…

Andy

Love0

News

May 16, 2023

Role of global public sector research in discovering new drugs and vaccines

Analysis of international public-sector contributions to Food and Drug Administration (FDA)-approved drugs and vaccines allows for a more thorough examination…

Andy

Love0

News

May 15, 2023

President Biden Announces Intent to Nominate Dr. Monica Bertagnolli as Director of the National Institutes of Health

Today (May 15, 2023), President Biden announced his intent to nominate Dr. Monica Bertagnolli as Director of the National Institutes…

Andy

Love0

News

May 15, 2023

BHI/NIH EIR Anna Zornosa Moderates Panel of Experts: Unlocking Reimbursement for Innovators in Maternal Health Solutions

Reimbursement is key to the success of innovators who have products, therapies, and new modes of service for expectant and…

Andy

Love0

News

May 15, 2023

BHI’s EIR Ethel Rubin, Ph.D., Joins JLABS @ NYC Roundtable

Ethel Rubin, Ph.D., an Entrepreneur-in-Residence at BioHealth Innovation, Inc. (BHI), recently participated in a “CEO Roundtable” for JLABS @ NYC.…

Andy

Love0

News

May 15, 2023

BHI EIR Renée JG Arnold Shares Expertise at the 28th Annual International ISPOR Meeting

Renée JG Arnold, PharmD, RPh, who serves as an Entrepreneur-in-Residence at BHI NHLBI EIR, recently moderated and participated in a…

Andy

Love0

News

From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of AMPEL BioSolutions, Joins BioTalk

Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee

PQE Group US Earns 2023 Great Place To Work Certification™

Baltimore’s Flavocure Biotech Announces FDA Clearance of IND Application for Caflanone (FBL-03G), for Clinical Trials in Pancreatic Cancer Patients.

REGENXBIO Announces NAV® Technology Platform Will Support Bespoke Gene Therapy Consortium’s First Rare Disease Clinical Portfolio

Role of global public sector research in discovering new drugs and vaccines

President Biden Announces Intent to Nominate Dr. Monica Bertagnolli as Director of the National Institutes of Health

BHI/NIH EIR Anna Zornosa Moderates Panel of Experts: Unlocking Reimbursement for Innovators in Maternal Health Solutions

BHI’s EIR Ethel Rubin, Ph.D., Joins JLABS @ NYC Roundtable

BHI EIR Renée JG Arnold Shares Expertise at the 28th Annual International ISPOR Meeting

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search